# Rosmalip® for Cancer Infections Prevention

> **NCT05080920** · NA · COMPLETED · sponsor: **Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares** · enrollment: 109 (actual)

## Conditions studied

- Infections
- Covid19
- Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Rosmalip®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05080920
- **Lead sponsor:** Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05080920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05080920, "Rosmalip® for Cancer Infections Prevention". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05080920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*